2013
Socioeconomic Disparities in the Use of Cardioprotective Medications Among Patients With Peripheral Artery Disease An Analysis of the American College of Cardiology's NCDR PINNACLE Registry
Subherwal S, Patel MR, Tang F, Smolderen KG, Jones WS, Tsai TT, Ting HH, Bhatt DL, Spertus JA, Chan PS. Socioeconomic Disparities in the Use of Cardioprotective Medications Among Patients With Peripheral Artery Disease An Analysis of the American College of Cardiology's NCDR PINNACLE Registry. Journal Of The American College Of Cardiology 2013, 62: 51-57. PMID: 23643497, PMCID: PMC3912073, DOI: 10.1016/j.jacc.2013.04.018.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseAntiplatelet therapyLow socioeconomic statusSocioeconomic statusCardioprotective medicationsPINNACLE RegistryPAD patientsPractice sitesClinical characteristicsArtery diseaseTreatment disparitiesTreatment of PADQuintile of SESPotential treatment disparitiesSecondary preventive medicationsSecondary preventive treatmentPatients' clinical characteristicsSecondary preventive measuresPatient's zip codeZip codesLowest SES quintileHighest SES quintileStatin medicationCardiovascular riskPreventive medications
2011
Secondary preventive medication persistence and adherence 1 year after stroke
Bushnell C, Olson D, Zhao X, Pan W, Zimmer L, Goldstein L, Alberts M, Fagan S, Fonarow G, Johnston S, Kidwell C, LaBresh K, Ovbiagele B, Schwamm L, Peterson E. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011, 77: 1182-1190. PMID: 21900638, PMCID: PMC3265047, DOI: 10.1212/wnl.0b013e31822f0423.Peer-Reviewed Original ResearchConceptsSecondary prevention medicationsPrevention medicationsSystem-level factorsMedication persistenceHospital dischargeIndependent predictorsIschemic stroke Longitudinal (AVAIL) registryGuidelines-Stroke programSecondary preventive medicationsUse of warfarinPrimary care providersAmerican Heart AssociationHealth care providers' instructionsLong-term useHospitalization dischargeModifiable patientDiabetes medicationsIschemic strokePreventive medicationsStroke patientsHeart AssociationCare providersMedicationsSide effectsPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply